2023
DOI: 10.1016/j.dsx.2023.102828
|View full text |Cite
|
Sign up to set email alerts
|

Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…In a recently published systematic review and meta-analysis, Khoa Ta et al [ 37 ] analyzed 33359 early-CRC cases and 14259289 controls included in 12 studies. A significant positive correlation was found between diabetes mellitus and an increased risk of early-CRC which suggests that diabetes mellitus is a risk factor for the development of early-CRC.…”
Section: Etiopathogenetic Factorsmentioning
confidence: 99%
See 1 more Smart Citation
“…In a recently published systematic review and meta-analysis, Khoa Ta et al [ 37 ] analyzed 33359 early-CRC cases and 14259289 controls included in 12 studies. A significant positive correlation was found between diabetes mellitus and an increased risk of early-CRC which suggests that diabetes mellitus is a risk factor for the development of early-CRC.…”
Section: Etiopathogenetic Factorsmentioning
confidence: 99%
“…A significant positive correlation was found between diabetes mellitus and an increased risk of early-CRC which suggests that diabetes mellitus is a risk factor for the development of early-CRC. The higher prevalence of diabetes mellitus among younger adults observed may contribute to the increasing incidence of early-CRC[ 37 ]. It is therefore concluded that decisive interventions to reduce this two-way risk should be studied more extensively as this will contribute to the development of effective prevention and treatment strategies.…”
Section: Etiopathogenetic Factorsmentioning
confidence: 99%
“…Identifying clinically significant subgroups is a cornerstone of personalized medicine, enabling the tailoring of treatments to patient characteristics that influence therapeutic outcomes. In clinical practice, a subset of patients are more likely to gain benefit from the current treatment, outweighing the harm [ 70 ], whereas some are at a greater probability of the opposing situation [ 71 ]. Identifying a subgroup of patients with a unique eigenvalue or effect emerges continuously across a broad range of medical fields [ 72 ], often with the goal of delineating patient risk stratification and facilitating optimal decision-making for varied patients.…”
Section: Aiming To Identify Clinically Significant Subgroupsmentioning
confidence: 99%
“…There are two ways in which one can use a variable to define a subgroup. The first is to directly use key baseline characteristics, including demographic variables such as age [ 76 ] and gender [ 77 , 78 ], as well as important clinical phenotypes [ 79 ], such as disease severity [ 71 ] and comorbidities [ 80 ], to define the subgroups in a separate or combined manner. By conducting subgroup analyses based on natural features, it is possible to uncover the heterogeneity of the intervention effects among target patients, thus enabling the selection of those who would most likely benefit from the intervention.…”
Section: Aiming To Identify Clinically Significant Subgroupsmentioning
confidence: 99%